BlackRock Health Sciences Trust (NYSE:BME) Shares Cross Below 50-Day Moving Average – Should You Sell?

BlackRock Health Sciences Trust (NYSE:BME) shares passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $39.90 and traded as low as $38.96. BlackRock Health Sciences Trust shares last traded at $39.26, with a volume of 33,077 shares.

BlackRock Health Sciences Trust Price Performance

The stock’s fifty day simple moving average is $39.90 and its 200-day simple moving average is $40.03.

BlackRock Health Sciences Trust Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Monday, March 31st. Investors of record on Friday, March 14th will be paid a $0.2621 dividend. This represents a $3.15 annualized dividend and a yield of 8.13%. The ex-dividend date is Friday, March 14th.

Institutional Trading of BlackRock Health Sciences Trust

A number of institutional investors have recently bought and sold shares of BME. Janney Montgomery Scott LLC raised its stake in shares of BlackRock Health Sciences Trust by 40.5% during the 4th quarter. Janney Montgomery Scott LLC now owns 32,787 shares of the company’s stock worth $1,244,000 after buying an additional 9,455 shares during the last quarter. Hara Capital LLC acquired a new position in BlackRock Health Sciences Trust during the fourth quarter worth about $832,000. Wolverine Asset Management LLC grew its position in shares of BlackRock Health Sciences Trust by 29.1% in the fourth quarter. Wolverine Asset Management LLC now owns 110,493 shares of the company’s stock valued at $4,191,000 after purchasing an additional 24,928 shares during the last quarter. HBK Sorce Advisory LLC increased its stake in shares of BlackRock Health Sciences Trust by 14.8% during the 4th quarter. HBK Sorce Advisory LLC now owns 8,194 shares of the company’s stock worth $311,000 after purchasing an additional 1,057 shares in the last quarter. Finally, AlphaStar Capital Management LLC purchased a new stake in BlackRock Health Sciences Trust in the 4th quarter valued at approximately $878,000.

BlackRock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.